基因复制
遗传学
比较基因组杂交
非等位同源重组
生物
基因座(遗传学)
拷贝数变化
17号染色体(人)
节段重复
基因剂量
基因
染色体
基因组
基因家族
遗传重组
重组
基因表达
作者
Oleg A. Shchelochkov,Sau Wai Cheung,James R. Lupski
摘要
Abstract Genomic disorders have been increasingly recognized as a significant source of clinically relevant phenotypes largely fostered by advances in technologies for genome‐wide analyses. Molecular and clinical studies of copy number variants involving chromosome 17 began with locus‐specific studies of Charcot–Marie–Tooth disease type 1A (CMT1A, OMIM #118220) and hereditary neuropathy with liability to pressure palsies (HNPP, OMIM #162500), which laid the foundation for the paradigm of duplication/deletion and gene‐dosage for our understanding of genomic disorders. With the clinical introduction of high‐resolution array comparative genomic hybridization (aCGH) the number of recognized genomic disorders including microduplications has been increasing rapidly. A relatively high proportion of disease‐associated copy number variants map to chromosome 17. This may result from its unique structural features, such as relative abundance of segmental duplications and interspersed repetitive elements, high gene content, and the presence of dosage‐sensitive genes. These genomic rearrangements are mediated by diverse mechanisms including Non‐Allelic Homologous Recombination (NAHR), Non‐Homologous End‐Joining (NHEJ), and Fork Stalling and Template Switching (FoSTeS). We provide specific examples of chromosome 17 microduplications with the emphasis on their phenotype, specific clinical features aiding in their diagnosis, and counseling. © 2010 Wiley‐Liss, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI